Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis

BACKGROUND: The minimum clinical important differences (MCIDs) of resilience instruments in patients with cancer have not been comprehensively described. This study was designed to evaluate MCIDs of 10-item and 25-item resilience scales specific to cancer (RS-SC-10 and RS-SC-25). METHODS: From June...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zeng Jie, Zhang, Zhang, Tang, Ying, Liang, Jian, Zhang, Xiao Ying, Hu, Guang Yun, Sun, Zhe, Liang, Mu Zi, Yu, Yuan Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724855/
https://www.ncbi.nlm.nih.gov/pubmed/33298059
http://dx.doi.org/10.1186/s12955-020-01631-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724855/
https://www.ncbi.nlm.nih.gov/pubmed/33298059
http://dx.doi.org/10.1186/s12955-020-01631-6

Ejemplares similares